Department of Bioscience and Oral Diagnosis, São José dos Campos Dental School, São Paulo State University, São José dos Campos, SP, Brazil.
Med Oral Patol Oral Cir Bucal. 2009 Nov 1;14(11):e563-7. doi: 10.4317/medoral.14.e563.
Although oral lichen planus has been classified by the World Health Organization (WHO) as a potentially malignant disorder, such classification is still the target of much controversy.
To evaluate the cell proliferation rate in oral lichen planus, comparing it to the rate observed in epithelial dysplasia and oral squamous cell carcinoma, aiming at indications which might indicate the potential for malignant transformation.
Twenty-four cases of each lesion were submitted to the streptoavidin-biotin and AgNOR technique to evaluate the immunohistochemical expression of PCNA and the mean NORs/nucleus, respectively.
Positivity for PCNA was observed in 58.33% of oral lichen planus cases, 83.33% of epithelial dysplasia cases and 91.67% of oral squamous cell carcinoma cases. Chi-squared test showed that the number of positive cases for PCNA was significantly lower in oral lichen planus than in oral squamous cell carcinoma (p<0.05). No significant statistical difference between oral lichen planus and epithelial dysplasia (p>0.05) and between the epithelial dysplasia and oral squamous cell carcinoma (p>0.05) was observed. The mean NORs/nucleus in oral lichen planus, epithelial dysplasia and oral squamous cell carcinoma were 1.74+/-0.32, 2.42+/-0.62 e 2.41+/-0.61, respectively. Variance analysis (ANOVA) revealed significant statistical difference between oral lichen planus and the other studied lesions (p<0.05).
Oral lichen planus cell proliferation rate was less than in oral epithelial dysplasia and oral squamous cell carcinoma which might explain the lower malignant transformation rate.
尽管口腔扁平苔藓已被世界卫生组织(WHO)列为一种潜在的恶性疾病,但这种分类仍然存在很大争议。
评估口腔扁平苔藓的细胞增殖率,并与上皮异型增生和口腔鳞状细胞癌的增殖率进行比较,以期为恶性转化的可能性提供指标。
对 24 例口腔扁平苔藓、上皮异型增生和口腔鳞状细胞癌的病变进行链霉亲和素-生物素和 AgNOR 技术检测,分别评估 PCNA 的免疫组化表达和平均 NORs/核。
口腔扁平苔藓病例中 PCNA 阳性率为 58.33%,上皮异型增生病例中为 83.33%,口腔鳞状细胞癌病例中为 91.67%。卡方检验显示,口腔扁平苔藓病例中 PCNA 阳性病例数明显低于口腔鳞状细胞癌病例(p<0.05)。口腔扁平苔藓与上皮异型增生病例(p>0.05)和上皮异型增生与口腔鳞状细胞癌病例(p>0.05)之间无显著统计学差异。口腔扁平苔藓、上皮异型增生和口腔鳞状细胞癌的平均 NORs/核分别为 1.74+/-0.32、2.42+/-0.62 和 2.41+/-0.61。方差分析(ANOVA)显示,口腔扁平苔藓与其他研究病变之间存在显著统计学差异(p<0.05)。
口腔扁平苔藓的细胞增殖率低于口腔上皮异型增生和口腔鳞状细胞癌,这可能解释了其较低的恶性转化率。